Global Statistics

All countries
Updated on September 25, 2022 6:41 pm
All countries
Updated on September 25, 2022 6:41 pm
All countries
Updated on September 25, 2022 6:41 pm

Global Statistics

All countries
Updated on September 25, 2022 6:41 pm
All countries
Updated on September 25, 2022 6:41 pm
All countries
Updated on September 25, 2022 6:41 pm
- Advertisment -

When Was Covid Vaccine Released

What Are The Side Effects For Each Vaccine

Moderna COVID-19 vaccine data released

According to Pfizer, about 3.8% of their clinical trial participants experienced fatigue as a side effect and 2% got a headache. The side effects remain similar among young adults and adolescents.

Younger teens receive the same vaccine dosage as adults and have reported the same side effects, mostly sore arms and flu-like fever, chills or aches that signal a revved-up immune system, particularly after the second dose. However, the CDC is also looking into rare reports of mild myocarditis in some younger recipients, though it remains unclear if the condition is in fact linked to the vaccine.

Children as young as 5 are experiencing less side effects overall, according to Dr. Jackie Korpics with Cook County Health. But when children do encounter side effects, they’re typically similar to the ones experienced by adults and usually after the second dose, too.

Moderna says 9.7% of their participants felt fatigued and 4.5% got a headache.

Like Pfizer and Moderna’s COVID-19 vaccines, the main side effects of the J& J shot are pain at the injection site and flu-like fever, fatigue and headache. These side effects usually start within a day or two of getting the vaccine, according to the CDC.

But the Johnson & Johnson vaccine was previously paused by U.S. regulators as they investigated reports of potentially dangerous blood clots known as cerebral venous sinus thrombosis, or CVST, in a small number of recipients.

  • Pain

Why Do We Need A Vaccine

It is more than a year since the virus first emerged, yet many people are still vulnerable.

The restrictions on our lives help keep the virus in check as they reduce opportunities for the virus to spread.

Vaccines teach our bodies to fight the infection and are “the” exit strategy from the pandemic.

What Did This Research Do

There are many different coronaviruses. SARS-CoV-2, the virus that causes COVID-19, is just one others can cause illnesses like the common cold.

Years before the COVID-19 pandemic began, experts at the NIH Vaccine Research Center were studying coronaviruses to find out how to protect against them. The scientists chose to focus on one prototype coronavirus and create a vaccine for it. That vaccine could then be customized to fight different coronaviruses. It was important that this vaccine be three things:

  • Fast. If a pandemic began like the COVID-19 pandemic did in late 2019 researchers would need to be able to adapt the vaccine and produce a lot of doses very quickly.
  • Reliable. The vaccine had to be extremely effective in humans.
  • Universal. The vaccine would have to work for many different coronaviruses, since it is not always possible to predict which viruses will spread quickly or become dangerous.

You May Like: How Much Is Covid Test At Cvs

Gallup: 36 Percent Of Us Employers Require Covid

Dec. 15 — The percentage of U.S. employers requiring workers to get vaccinated against COVID-19 has flattened at 36%, according to a Gallup poll released Wednesday.

According to the Nov. 29-Dec. 5 Gallup tracking survey , 36 percent of workers said their employers are requiring COVID-19 vaccination. That was unchanged from October tracking survey results.

Meanwhile, 55 percent of U.S. workers support COVID-19 vaccine requirements at work, while 35 percent of workers oppose them.

Gallup’s tracking survey results show 1 in 5 workers are still unvaccinated. The survey is based on a nationally representative sample of more than 2,000 workers.

In September, Gallup found that a majority — roughly 6 in 10 — of workers support President Joe Biden‘s plan to mandate vaccines for millions of U.S. workers.

But since then, courts have blocked mandates for federal workers and workers at big private employers. Several states sued the Biden administration over those mandates.

Gallup says 46 percent of employers are “encouraging vaccination.” That percentage was down from 66 percent in May.

The U.S. Centers for DIsease Control and Prevention says 72.2 percent of Americans have received at least one COVID-19 vaccine dose.

Is It True Were Covid


It may seem vaccines were developed quickly, but researchers around the world have been working hard to develop vaccines from the start of the pandemic. They were able to speed up development thanks to the collaboration between them, scientists, manufacturers and distributors. Find out more below.

  • Listen

Read Also: How Long Does The Cvs Covid Test Take

What Are The Promising Vaccines For Covid

Around the world, there are currently nearly 150 different COVID-19 vaccines in various stages of testing and development: phase 1 , phase 2 , and phase 3 trials in humans.

In the US, the FDA has granted full approval to the Pfizer/BioNTech mRNA COVID-19 vaccine, and emergency use authorization to the Moderna mRNA vaccine and the Johnson & Johnson adenovirus vaccine.

Two other vaccine approaches are also showing promise.

A central question for COVID-19 vaccines will be how long protection might last.

Does Age Matter For Vaccinations

Pfizer’s vaccine is also currently the only vaccine authorized for emergency use in children as young as 5. Both Moderna and J& J’s vaccines can only be used on people 18 and older.

Both Pfizer and Moderna have also started studies in the U.S. surrounding the vaccine and children as young as 6 months.

Also Check: Cvs Pcr Test For Travel Cost

What Are Mrna Vaccines And How Do They Work To Help Prevent Covid

mRNA, or messenger RNA, is genetic material that contains instructions for making proteins. mRNA vaccines for COVID-19 contain synthetic mRNA. Inside the body, the mRNA enters human cells and instructs them to produce the “spike” protein found on the surface of SARS-CoV-2, the virus that causes COVID-19. The body recognizes the spike protein as an invader, and starts producing antibodies against it. Soon after, the cell breaks down the mRNA into harmless pieces If the antibodies later encounter the actual virus, they are ready to recognize and destroy it before it causes illness.

Two mRNA vaccines, one created by Pfizer and BioNTech and another developed by Moderna, were granted emergency use authorization by the FDA in December 2020. In August 2021, the FDA granted full approval to the Pfizer/BioNTech COVID-19 mRNA vaccine for use in people ages 16 years and older. The transition from EUA status to full licensure was based on additional data and longer follow-up showing that the vaccine met certain safety, effectiveness, and manufacturing quality standards.

What Is The Rest Of The World Doing

Local doctors skeptical about Covid-19 vaccines being released too early

There are other noteworthy vaccines, even if they are not being used in Europe and the US.

The Sinovac, CanSino and Sinopharm vaccines have been developed by scientists in China and deals have signed with other countries in Asia and South America. Around one million people in China are reported to have been given the Sinopharm injection.

The Sputnik V vaccine, developed by Russia’s Gamaleya Research Centre, is also effective according to late stage trial results published in The Lancet. Some people have been immunised.

The vaccine, which works in a similar way to the Oxford-AstraZeneca and Janssen vaccines has also been deemed to be safe – and offer complete protection against hospitalisation and death.

Also Check: Antigen Test At Cvs

Cdc Recommends Pediatric Covid

Contact:Media Relations 639-3286

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices recommendation that children 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine. CDC now expands vaccine recommendations to about 28 million children in the United States in this age group and allows providers to begin vaccinating them as soon as possible.

COVID-19 cases in children can result in hospitalizations, deaths, MIS-C and long-term complications, such as long COVID, in which symptoms can linger for months. The spread of the Delta variant resulted in a surge of COVID-19 cases in children throughout the summer. During a 6-week period in late June to mid-August, COVID-19 hospitalizations among children and adolescents increased fivefold. Vaccination, along with other preventative measures, can protect children from COVID-19 using the safe and effective vaccines already recommended for use in adolescents and adults in the United States. Similar to what was seen in adult vaccine trials, vaccination was nearly 91 percent effective in preventing COVID-19 among children aged 5-11 years. In clinical trials, vaccine side effects were mild, self-limiting, and similar to those seen in adults and with other vaccines recommended for children. The most common side effect was a sore arm.

The following is attributable to Dr.Walensky:

Concerns Over Mrna Vaccine

According to Dr. Kenyon, misinformation surrounding mRNA vaccines stems from a concern that the vaccine infects people with the virus.

Nobody is getting infected with a COVID vaccine. It is only the surface protein that would be replicated because we have given you the messenger RNA. It is not the entire virus, he explained.

One misconception is that an mRNA vaccine would not be useful if the virus mutates.

A July study published in Frontiers in Microbiologyconfirms that the virus mutates. After analyzing 48,635 samples of SARS-CoV-2, the researchers identified an average of 7.23 mutations per sample.

A more recent study, published in November in , found that a D614G mutation in the S protein made it more infectious. However, there was no evidence to suggest a link between the mutation and more severe illness.

While mutations are possible, Dr. Sun said it should not be a cause for alarm.

There has been an estimated 250,000 variants or strains of SARS-CoV-2 sequenced in the lab. For the most part, the virus has a low mutation rate compared to the mutation rate of the influenza virus , Dr. Sun explained. The spike protein is important for the ability of the virus to infect humans cells. I think it would not mutate enough for the vaccines to be ineffective.

In addition, according to Dr. Parry, virologists are continually monitoring and examining for any significant changes from new strains of the virus.

Read Also: How Much Does Cvs Covid Test Cost

Im Vaccinated What Can I Do Now

Fully vaccinated people can participate in most indoor and outdoor activities without a mask and without physical distancing. In July 2021, the CDC advised all people, including those who are fully vaccinated, to wear masks in public indoor places in areas of the country with substantial or high transmission of the virus.

In addition, youll still need to follow federal, state, tribal, and local laws, and workplace or business requirements around mask wearing and physical distancing.

For people who are not fully vaccinated, the CDC continues to recommend mask wearing and other preventive measures in some outdoors settings and in most indoor settings.

What Needed To Happen Before The Fda Authorized Or Approved A Vaccine For Covid

COVID Vaccine Released For Those 65 and Older

A successful COVID-19 vaccine had to safely and effectively stimulate the body’s immune system to create antibodies that protect against the COVID-19 coronavirus. In December 2020, the FDA granted emergency use authorization to an mRNA COVID-19 vaccine developed by Pfizer and BioNTech. One week later, the FDA granted EUA to another mRNA COVID-19 vaccine, this one developed by Moderna. In February 2021, the FDA granted EUA to an adenovirus vaccine developed by Johnson & Johnson. And in August 2021, the FDA granted full approval to the Pfizer/BioNTech COVID-19 mRNA vaccine for use in people ages 16 years and older.

Approval of a vaccine requires completion of the following steps:

The transition from EUA status to full licensure of the Pfizer/BioNTech vaccine was based on additional data and longer follow-up showing that the vaccine met certain safety, effectiveness, and manufacturing quality standards. Safety data will continue to be collected and monitored.

You May Like: How Much Is Covid Test At Cvs

A Decade Of Mrna Vaccine Research

Researchers have been developing and researching an mRNA vaccine platform for over 10 years. After SARS-CoV-2 was sequenced, it took just a few days to make the mRNA vaccine candidates. The spike proteins genetic code was plugged into preexisting technology with an already working process that had been evaluated for other vaccine uses, such as in the fight against dengue.

When Will The General Public Be Able To Get Vaccinated

Regarding who will be next in line for the subsequent rollout phases, the ACIP has named as priority groups workers in essential and critical industries, people at high risk for severe COVID-19 illness due to underlying medical conditions, people 65 years and older. In an ACIP meeting in September, the agency estimated that there are as many as 80 million essential workers and 53 million people above the age of 65 all of whom would require two doses each.

But key questions remain, particularly in the determination of which underlying medical conditions will inform vaccine prioritization. While the CDC notes that illnesses being considered are ones that put individuals at higher risk of hospitalization or death, many underlying conditions including those with heart failure, cancer, or sickle-cell disease are on that list. Another health condition that the agency is considering is obesity, which, according to one study, makes individuals 113 percent more likely to be hospitalized, 74 percent more likely to be admitted to intensive-care units, and 48 percent more likely to die of COVID-19. Governors will also face the challenge of determining whether and how to factor in race, as Black, Indigenous, and Latin Americans have experienced disproportionate rates of hospitalization and death owing to the coronavirus and systems will probably vary widely among states.

Read Also: Hank Aaron Dies After Vaccine

Encouragement By Public Figures And Celebrities

Many public figures and celebrities have publicly declared that they have been vaccinated against COVID19, and encouraged people to get vaccinated. Many have made video recordings or otherwise documented their vaccination. They do this partly to counteract vaccine hesitancy and COVID19 vaccine conspiracy theories.


Elizabeth II and Prince Philip announced they had the vaccine, breaking from protocol of keeping the British royal family‘s health private.Pope Francis and Pope Emeritus Benedict both announced they had been vaccinated.

Media personalities

Dolly Parton recorded herself getting vaccinated with the Moderna vaccine she helped fund, she encouraged people to get vaccinated and created a new version of her song “Jolene” called “Vaccine”. Several other musicians like Patti Smith, Yo-Yo Ma, Carole King, Tony Bennett, Mavis Staples, Brian Wilson, Joel Grey, Loretta Lynn, Willie Nelson, and Paul Stanley have all released photographs of them being vaccinated and encouraged others to do so. Grey stated “I got the vaccine because I want to be safe. We’ve lost so many people to COVID. I’ve lost a few friends. It’s heartbreaking. Frightening.”


Magic Johnson and Kareem Abdul-Jabbar released photographs of themselves getting vaccinated and encouraged others to do the same Abdul-Jabbar said, “We have to find new ways to keep each other safe.”

Specific communities

What Do We Know About The Astrazeneca Adenovirus Covid

FDA releases new details about COVID-19 vaccine

An analysis of Phase 3 clinical trial data suggests that the COVID-19 vaccine developed by AstraZeneca and the University of Oxford is effective and safe. AstraZeneca presented interim results in a press release on March 22, 2021. Within a day, however, the National Institutes of Allergy and Infectious Diseases released a statement expressing concern that AstraZeneca’s analysis may contain outdated information and may provide “an incomplete view of the efficacy data.” On March 25th, AstraZeneca released a new analysis, also in a press release, that included more recent trial data. The FDA will have the opportunity to carefully examine and conduct its own analysis of all of the trial data when AstraZeneca applies for emergency use authorization , which is expected to happen in the coming weeks.

According to AstraZeneca’s most recent analysis, vaccine recipients were 76% less likely to develop symptomatic COVID infection than those who received a placebo. The vaccine was also 100% effective for protecting against severe COVID and hospitalization there were eight cases of severe COVID in the placebo group, compared to none in the vaccine group.

The analysis looked at results from a trial of about 32,000 participants from the US, France, Chile, and Peru. Two-thirds of the study participants were randomly selected to received two doses of the vaccine, spaced four weeks apart. The remaining one-third of participants got a saltwater placebo.

Don’t Miss: How Much For Covid Test At Cvs

How Much Will The Vaccines Cost

The Trump administration has promised to offer the COVID-19 vaccines to the public free of charge, at least initially, and has already invested nearly $8 billion to purchase hundreds of millions of doses. The plan is for at least the first round of coronavirus vaccinations to be available free of cost to everyone, including those without insurance. However, as is always the case with anything to do with the American health-care system, it remains to be seen how, exactly, that will all play out once the billing actually starts.

For instance, there is the matter of possible administration or office-visit fees charged by the vaccine providers, which, according to the CDC, can be reimbursed by insurers, or, for the uninsured, by the Health Resources and Services Administrations Provider Relief Fund. How easy that will be for the uninsured is not clear.

Its also worth noting that the vaccine would have already been free for the vast majority Americans with insurance, as the Affordable Care Act requires insurers to cover any federally recommended vaccines with no out-of-pocket costs. That does not apply, however, to people on short-term plans, which have no federal coverage requirements.

As far as how much individual vaccine doses will cost the government or insurance companies, the current leading vaccine candidates are expected to cost anywhere from $3 to $37 per dose.

Book Your Free Shot It’s Safe And Easy

COVID-19 vaccines help prevent you from getting infected and protect you from getting severely sick if you do get it. All vaccines are safe, effective and save lives.

Everyone born in 2009 or before can get their first and second doses now. Third doses are available to some people most at risk of severe illness.

NEW: AHS clinics and pharmacies now use the same centralized online booking system. You can also book your shot by calling 811, visiting a walk-in clinic, or contacting a doctor’s office.

  • 78.8% of Albertans 12+ with at least 1 dose
  • 70.8% of Albertans 12+ fully vaccinated
  • $100 Debit Card

    Get vaccinated to get a $100 debit card!

  • Who’s eligible: Albertans 18 or older who got their first or second dose of an approved COVID-19 vaccine between September 3 and October 14, 2021.
  • How to register: After vaccination, register online or by phone, starting on September 13. Detailed instructions will be posted at that time.
  • How to claim: $100 debit cards will be delivered to you. Everyone who is registered and has a valid vaccination will receive a debit card.
  • Open for Summer Lottery

    Get vaccinated for your shot to win $1 million!

  • Who’s eligible: Alberta residents 18 and older who have had 2 doses of an approved COVID-19 vaccine.
  • How to register: Enter online at by September 23 at 11:59 pm.
  • How to claim: Winner will be contacted by September 30, 2021.
  • Who’s eligible: Alberta residents 18 and older with 2 doses of an approved COVID-19 vaccine.
  • You May Like: Why Does Everything Taste Bad To Me Suddenly Covid

    - Advertisment -

    Hot Topics

    - Advertisment -

    Related Articles